ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag alternative splicing disease medicine immunology

3D image of a neuron cell network with a red glow representing inflammation.
New Insight into Brain Inflammation Inspires New Hope for Epilepsy Treatment 
Deanna MacNeil, PhD | Jun 1, 2023 | 2 min read
Clinicians and researchers teamed up to investigate how inappropriate proinflammatory mechanisms contribute to the pathogenesis of drug-refractory epilepsy.
CAR Ts solid tumor
The Next Frontier of CAR T-Cell Therapy: Solid Tumors
Kerry Grens | Apr 1, 2019 | 10+ min read
The technology has wowed the field by all but obliterating some patients’ blood cancers, but solid malignancies present new challenges.
Lighting Up Life in Real Time
Aileen Constans | Jun 9, 2002 | 2 min read
In recent years scientists have exploited the light-generating capability of luciferase in applications ranging from apoptosis detection to DNA quantitation. Now Alameda, Calif.-based Xenogen has taken this useful enzyme one step further, with a luciferase-based system for studying infectious diseases, cancer, and metabolic diseases in living animals in real time. Xenogen has developed Bioware™ animal models, in which pathogens, target genes, or tumor cells are tagged with luciferase, whi
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
Top 10 Innovations 2013
The Scientist | Dec 1, 2013 | 10+ min read
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
2018 Top 10 Innovations
The Scientist | Dec 1, 2018 | 10+ min read
Biology happens on many levels, from ecosystems to electron transport chains. These tools may help spur discoveries at all of life's scales.
Hot Papers
The Scientist Staff | Oct 1, 1990 | 5 min read
D.A. Cheresh, J.W. Smith, H.M. Cooper, V. Quaranta, "A novel vitronectin receptor integrin (Aváx) is responsible for distinct adhesive properties of carcinoma cells," Cell, 57, 59-69, 7 April 1989. David A. Cheresh (Research Institute of Scripps Clinic, La Jolla, Calif.): "Cellular adhesion events are required for normal embryonic development, wound healing, thrombosis, and immune function. However, during disease processes (such as cancer, microbial infection, and inflammation), some of
How Cancers Evolve Drug Resistance
Anna Azvolinsky | Apr 1, 2017 | 10+ min read
Researchers unravel the sophisticated ways cancers evade treatments, including immunotherapies, designed to destroy them.
Macrophages Play a Double Role in Cancer
Amanda B. Keener | Apr 1, 2018 | 10+ min read
Macrophages play numerous roles within tumors, leaving cancer researchers with a choice: eliminate the cells or recruit them.

Run a Search

ADVERTISEMENT